Icogenex Corporation

Icogenex is a Seattle-based, privately held company identifying and developing therapeutic compounds for the treatment of human diseases.

In pursuit of this goal, Icogenex has developed ICOCEPT^TM, a technologically advanced high through-put screening methodology that has broad application in protein effector discovery.

Implementing this technology, we are working toward in-house drug development, as well as partnerships with pharmaceutical companies in protein effector discovery programs.

Icogenex also has proven capability in expressing proteins from bacteria, yeast, or mammalian cells with a process called "IcoExpress^TM". The Company has partnered or contracted on projects utilizing IcoExpress to assist other companies in expressing therapeutic proteins.

For more information, please contact us.